MY
NEWSLETTER Fall 2015/Winter 2016 DR EDELMAN’S CORNER
Blinded CGM... Give Me A Break Inside PA G E 3
Smart Patients PA G E 4
Tresiba and Toujeo PA G E 6
In Memory: Joseph F. Kunz PA G E 7
Puracyn PA G E 8
Eating Better: We Need A Plan! PA G E 9
Case of the Month PA G E 1 0
The Game Changer PA G E 1 1
Eating Well
Continuous glucose monitoring (CGM) has been around for a decade and, according to me, it is the single greatest advance for people with type 1 diabetes since the discovery of insulin, which was almost a century ago! For those of you who don’t know about it, CGM allows a person with diabetes to have a blood sugar reading every five minutes, 24/7, with trend arrows to show which direction the blood sugar is going and sounds an alert for impending highs and dangerous lows. CGM has already improved the lives of thousands of infants, children, and adults living with diabetes, as well as their loved ones. There are two CGM devices currently on the market, the Dexcom G5 and Medtronic Enlite. These devices have traditionally been used for folks with type 1 diabetes; however, they will soon be used to a much greater extent by people with type 2 diabetes! While it may seem obvious to use an unblinded CGM, many healthcare providers (HCP) use blinded CGM. This is where the person with diabetes wears a CGM device for three to five days but cannot see any of the glucose values. Additionally, no alarms will go off even
if the glucose value is extremely high or dangerously low. You will not see trend arrows and are unable to see how food, exercise, stress, and other factors affect your diabetes control. The CGM, which ends up being a loaner unit, is returned to the clinic or doctor’s office and the data is downloaded there. When you see that HCP again (whenever that will be), you go over the results in retrospect, hoping to find trends and patterns in order to make therapeutic decisions in your diabetes management. I just do not understand the concept around blinding a person with diabetes from their results in real-time. Why C O N T I N U E D O N PA G E 2